Expansion of CD4 T Lymphocytes Expressing Interleukin 17 and Tumor Necrosis Factor in Patients with Major Depressive Disorder
Open accessThe DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.
Abstract
Background: We have investigated the distribution of the Th1, Th2 and Th17 subsets in circulating CD4+ T lymphocytes and their naïve (TN), effector (TE), central (TCM) and effector memory (TEM) activation/differentiation stages in patients with major depressive disorder (MDD). Methods: Thirty MDD patients and 30 healthy controls were studied. The counts of circulating CD4+ T lymphocytes and their distribution on the TN, TE, TCM and TEM activation/differentiation stages were analyzed by polychromatic flow cytometry. The intracytoplasmic interferon gamma (IFNγ), interleukin (IL)-4, IL-17A and tumor necrosis factor alpha (TNF-alpha) and membrane CD28 expression were also measured. The serum IFNγ, IL-4, Il-17A and TNF-alpha were measured by Luminex, respectively. Results: MDD patients had normal counts of CD4+ T lymphocytes and of their TN, TCM and TEM subsets but increased number and percentage of TE CD4+ subset. CD4+ T lymphocytes had significantly enhanced percentage of cells that express IL-17 and TNF-alpha explained by the expansions found in the TN, TCM and, TEM and TCM, TEM and TE activation/differentiation stages, respectively. A selective increase in the percentages of TCM and TEM expressing IFNγ was also observed. We found a significant correlation between the percentages of CD4+ T lymphocytes expressing IFNγ and TNF-alpha in these patients. MDD patients showed increased serum levels of IL-17 and TNF-alpha, but normal IFNγ and IL-4 concentration. Limitations: the cross-sectional nature of the study could be considered a limitation. Conclusions: MDD patients have abnormal circulating CD4+ T lymphocytes with expansion of the IL-17 and TNF-alpha expressing cells as well as increased levels of circulating IL-17 and TNF-alpha.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The study data showed that the circulating Th17 cell count was higher with corresponding increased serum levels of IL-17-A.”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [147]
In the citing paper
“The IL-17A overexpression was observed in various activation/differentiation stages of CD4+ T cells, namely the naïve, central memory, and effector memory T cells [147].”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [147]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
(1998) · PubMed · Cited by 10,216
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942 · cited 1×
“Low-grade inflammation has been shown to influence neurotransmission, that is an important determinant in MDD pathogenesis and response to treatment [25].”
BackgroundCentral Memory and Effector Memory T Cell Subsets: Function, Generation, and Maintenance
Sallusto, F., Geginat, J., & Lanzavecchia, A. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104702 · Cited by 3,067
Effector and memory T-cell differentiation: implications for vaccine development
Kaech, S. M., Wherry, E. J., & Ahmed, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri778 · Cited by 1,865 · cited 1×
“TN exhibit non-effector functions while TCM show high rates of proliferation and express multiple effector molecules, such as cytokines, in response to antigen stimulation and less intensive activation requirements [11,12].”
BackgroundRaison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617
Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies
Köhler, C. A., Freitas, T. H., Maes, M., de Andrade, N. Q., Liu, C. S., Fernandes, B. S., Stubbs, B., Solmi, M., Veronese, N., Herrmann, N., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12698 · Cited by 1,443 · cited 1×
“Although contradictory results have been published, there is a general consensus indicating that MDD patients have abnormal circulating levels of pro-inflammatory and regulatory cytokines [15].”
Standardizing immunophenotyping for the Human Immunology Project
Maecker, H. T., McCoy, J. P., & Nussenblatt, R. (2012) · Nature Reviews Immunology · doi:10.1038/nri3158 · Cited by 1,176 · cited 2×
“Therefore, it has been proposed that CD4+ T lymphocyte subsets include CD45RA+CCR7+ naïve (TN), CD45RA-CCR7+ central memory (TCM), CD45RA-CCR7- effector memory (TEM) and CD45RA+CCR7- effector (TE) subsets [10].”
BackgroundThe Relationship of Depression and Stressors to Immunological Assays: A Meta-Analytic Review
Zorrilla, E. P., Luborsky, L., McKay, J. R., Rosenthal, R., Houldin, A., Tax, A., McCorkle, R., Seligman, D. A., & Schmidt, K. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0597 · Cited by 995
Köhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1611 · Cited by 941
Kappelmann, N., Lewis, G., Dantzer, R., Jones, P. B., & Khandaker, G. M. (2018) · Molecular Psychiatry · doi:10.1038/mp.2016.167 · Cited by 659
Liu, J. J., Wei, Y. B., Strawbridge, R., Bao, Y., Chang, S., Shi, L., Que, J., Gadad, B. S., Trivedi, M. H., Kelsoe, J. R., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0474-5 · Cited by 429 · cited 1×
“Increased levels of tumor necrosis factor (TNF-alpha), a critical pro-inflammatory and regulatory cytokine, have been found in patients with MDD [16].”
BackgroundSTATs Shape the Active Enhancer Landscape of T Cell Populations
Vahedi, G., Takahashi, H., Nakayamada, S., Sun, H.-W., Sartorelli, V., Kanno, Y., & O’Shea, J. J. (2012) · Cell · doi:10.1016/j.cell.2012.09.044 · Cited by 367 · cited 1×
“The critical difference in the expression of these membrane molecules is the kinesis of their loss or acquisition throughout the different T activation/differentiation stages [9].”
BackgroundHeterogeneity of CD4+ memory T cells: Functional modules for tailored immunity
Sallusto, F., & Lanzavecchia, A. (2009) · European Journal of Immunology · doi:10.1002/eji.200939722 · Cited by 348 · cited 2×
“In addition to the different requirements for activation, proliferation and survival, TN, TCM, TEM and TE subsets also show a distinct capacity between them in terms of entering lymphoid and non-lymphoid inflamed tissues [14].”
BackgroundHaroon, E., Daguanno, A. W., Woolwine, B. J., Goldsmith, D. R., Baer, W. M., Wommack, E. C., Felger, J. C., & Miller, A. H. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.05.026 · Cited by 291 · cited 1×
“Our results assist in explaining the claimed relevance of IL-17 and TNF-alpha in the pathogenesis of MDD [31,32].”
ResultRegulation of human helper T cell subset differentiation by cytokines
Schmitt, N., & Ueno, H. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.03.007 · Cited by 249 · cited 1×
“CD4+ T lymphocyte subsets are characterized by their capacity to produce cytokines such as interferon (IFN)γ, interleukin (IL)-4 or IL-17A, and are subsequently referred to as Th1, Th2 and Th17, respectively [8].”
BackgroundArteaga-Henríquez, G., Simon, M. S., Burger, B., Weidinger, E., Wijkhuijs, A., Arolt, V., Birkenhager, T. K., Musil, R., Müller, N., & Drexhage, H. A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00458 · Cited by 215 · cited 1×
“In fact, previous reports show that patients with MDD with an activated inflammatory state show reduced responses rates to antidepressants [26].”
BackgroundChen, Y., Jiang, T., Chen, P., Ouyang, J., Xu, G., Zeng, Z., & Sun, Y. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2010.10.029 · Cited by 209 · cited 1×
“Furthermore, the serum levels IL-17A have also been found to be normal or elevated in MDD patients, with some reports also showing increased concentrations of serum IFNγ [17,18].”
BackgroundWang, L., Wang, R., Liu, L., Qiao, D., Baldwin, D. S., & Hou, R. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.02.021 · Cited by 185 · cited 1×
“It is important to note, that antidepressants might have an immunomodulatory effect [41,42].”
BackgroundT-cell aging in rheumatoid arthritis
Weyand, C. M., Yang, Z., & Goronzy, J. J. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000011 · Cited by 164 · cited 1×
“However, we have found a significant increase in the number and percentage of CD28- TE subset in MDD patients that is considered as a senescence marker [40].”
BackgroundPhenotypic classification of human CD4+ T cell subsets and their differentiation
Okada, R., Kondo, T., Matsuki, F., Takata, H., & Takiguchi, M. (2008) · International Immunology · doi:10.1093/intimm/dxn075 · Cited by 142
Davami, M., Baharlou, R., Ahmadi Vasmehjani, A., Ghanizadeh, A., Keshtkar, M., Dezhkam, I., & Atashzar, M. (2016) · Basic and Clinical Neuroscience Journal · doi:10.15412/j.bcn.03070207 · Cited by 124
Depression and suicidality: A link to premature T helper cell aging and increased Th17 cells
Schiweck, C., Valles-Colomer, M., Arolt, V., Müller, N., Raes, J., Wijkhuijs, A., Claes, S., Drexhage, H., & Vrieze, E. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.02.005 · Cited by 114 · cited 1×
“These results are aligned with the recently described expansion of memory and Th17 CD4+ T lymphocytes in patients with depression exhibiting a high risk of suicide [28].”
ResultSlyepchenko, A., Maes, M., Köhler, C. A., Anderson, G., Quevedo, J., Alves, G. S., Berk, M., Fernandes, B. S., & Carvalho, A. F. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.002 · Cited by 89 · cited 1×
“Our results assist in explaining the claimed relevance of IL-17 and TNF-alpha in the pathogenesis of MDD [31,32].”
Alvarez-Mon, M. A., Gómez, A. M., Orozco, A., Lahera, G., Sosa, M. D., Diaz, D., Auba, E., Albillos, A., Monserrat, J., & Alvarez-Mon, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00812 · Cited by 86 · cited 1×
“An abnormal immune response within a systemic inflammatory environment has been involved in the pathogenesis of depression [20].”
BackgroundSelf-citationJha, M. K., Minhajuddin, A., Gadad, B. S., Greer, T. L., Mayes, T. L., & Trivedi, M. H. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.07.005 · Cited by 79 · cited 1×
“Thus, it is possible to suggest that IL-17 might be considered a potentially new target for the personalized treatment of depression [37,38].”
BackgroundKim, J.-W., Kim, Y.-K., Hwang, J.-A., Yoon, H.-K., Ko, Y.-H., Han, C., Lee, H.-J., Ham, B.-J., & Lee, H. S. (2013) · Psychiatry Investigation · doi:10.4306/pi.2013.10.3.294 · Cited by 77
Hernández, M. E., Martínez‐Fong, D., Pérez-Tapia, M., Estrada‐García, I., Estrada-Parra, S. A., & Pavón, L. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.11.005 · Cited by 72 · cited 1×
“It is important to note, that antidepressants might have an immunomodulatory effect [41,42].”
BackgroundA dynamic course of T cell defects in individuals at risk for mood disorders
Snijders, G. J. L., Schiweck, C., Mesman, E., Grosse, L., Wit, H. D., Nolen, W. A., Drexhage, H. A., & Hillegers, M. H. J. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.05.007 · Cited by 67
Lee, Y., Subramaniapillai, M., Brietzke, E., Mansur, R. B., Ho, R. C., Yim, S. J., & McIntyre, R. S. (2018) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125318791944 · Cited by 62 · cited 1×
“Furthermore, there is evidence supporting biologics specifically targeting individual cytokines (mainly TNF-alpha and IL-6) as effective in reducing depressive symptoms in a subset of MDD patients [4,35].”
BackgroundBecking, K., Haarman, B. C. M., Grosse, L., Nolen, W. A., Claes, S., Arolt, V., Schoevers, R. A., & Drexhage, H. A. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.03.004 · Cited by 61 · cited 1×
“These results may explain the previously described heterogeneity evidenced among studies on CD4+ T lymphocyte cytokine production in MDD patients [33].”
ResultTaylor, J. J., & Jenkins, M. K. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.03.010 · Cited by 52 · cited 1×
“TEM also expresses effector cytokines but has reduced proliferative capacity while TE is at a final differentiation stage, exhibiting increased levels of cytokine production [13].”
BackgroundCirculating T helper 17 and IFN-γ positive Th17 cells in Major Depressive Disorder
Ghosh, R., Kumar, P. K., Mitra, P., Purohit, P., Nebhinani, N., & Sharma, P. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112811 · Cited by 47 · cited 1×
“Furthermore, the serum levels IL-17A have also been found to be normal or elevated in MDD patients, with some reports also showing increased concentrations of serum IFNγ [17,18].”
BackgroundModulation of CD4 T Cell Response According to Tumor Cytokine Microenvironment
Accogli, T., Bruchard, M., & Végran, F. (2021) · Cancers · doi:10.3390/cancers13030373 · Cited by 45 · cited 1×
“There is evidence supporting the relevance of the cytokine microenvironment in the differentiation of naïve T lymphocytes into Th1, Th2 and Th17 subsets [30].”
BackgroundAlvarez-Mon, M. A., Gomez-Lahoz, A. M., Orozco, A., Lahera, G., Sosa-Reina, M. D., Diaz, D., Albillos, A., Quintero, J., Molero, P., Monserrat, J., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.591962 · Cited by 44 · cited 1×
“The relevance of the predisposition and acquired activation of CD4+ T lymphocytes to express cytokines is supported by the observation of opposing results with respect to IFNγ and TNF-alpha production in MDD patients [29].”
ResultSelf-citationHennings, J. M., Uhr, M., Klengel, T., Weber, P., Pütz, B., Touma, C., Czamara, D., Ising, M., Holsboer, F., & Lucae, S. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.9 · Cited by 42 · cited 1×
“Thus, it is possible to suggest that IL-17 might be considered a potentially new target for the personalized treatment of depression [37,38].”
BackgroundAntidepressant Drug, Desipramine, Alleviates Allergic Rhinitis by Regulating Treg and Th 17 Cells
Zhang, Y., Zhen, H., Yao, W., Bian, F., Mao, X., Yang, X., & Jin, S. (2013) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201302600110 · Cited by 38 · cited 1×
“Furthermore, with this study strategy, we avoided the described modulation of Th2 CD4+ T lymphocytes associated with effective antidepressant treatment, no matter the antidepressant prescribed [27].”
MethodMonserrat, J., Heras, C. B., Gomez-Lahoz, A. M., Movasat, A., Pérez, A., Ruiz, L., Díaz, D., Chara, L. E., Sánchez, A. I., Albarrán, F., et al. (2019) · Cells · doi:10.3390/cells8080871 · Cited by 18 · cited 1×
“It is known that chronic longterm inflammatory diseases are associated with a reduction in the number of TN stages and an increase in the percentage of CD28- CD4+ T lymphocytes [39].”
BackgroundSelf-citationThe many faces of CD4 T cells: Roles in immunity and disease
Sallusto, F., & Monticelli, S. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.11.001 · Cited by 13 · cited 1×
“The activity of the different Th1, Th2 and Th17 CD4+ T lymphocytes is crucial for the induction of a proinflammatory and effector pattern immune response [7].”
BackgroundNiemegeers, P., de Boer, P., Schuermans, J., Dumont, G. J. H., Coppens, V., Spittaels, K., Claes, S., Sabbe, B. G. C., & Morrens, M. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.11.020 · Cited by 12 · cited 1×
“Both experimental and human findings have underlined the relevance of abnormal immune-inflammatory response in the pathogenesis of depression [3].”
Background
Research works printed but not linked: 1
- Malhi, G.S., and Mann, J.J. (2018, November 24). Depression. Lancet, Available online: https://linkinghub.elsevier.com/retrieve/pii/S0140673618319482.
Cited by
Selected biomarkers of depression: what are the effects of cytokines and inflammation
Harsanyi, S., Kupcova, I., Danisovic, L., & Klein, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010578 · Cited by 299
Kouba, B. R., de Araujo Borba, L., Borges de Souza, P., Gil-Mohapel, J., & Rodrigues, A. L. S. (2024) · Cells · doi:10.3390/cells13050423 · Cited by 209
“In line with this, a greater propensity for Th17 differentiation has been observed in individuals with MDD [157].”
BackgroundOrtega, M. A., Alvarez-Mon, M. A., García-Montero, C., Fraile-Martinez, O., Guijarro, L. G., Lahera, G., Monserrat, J., Valls, P., Mora, F., Rodríguez-Jiménez, R., et al. (2022) · Metabolites · doi:10.3390/metabo12010050 · Cited by 123
Self-citationThe Role of IL-17 Cytokines in Psoriasis
Mosca, M., Hong, J., Hadeler, E., Hakimi, M., Liao, W. J., & Bhutani, T. (2021) · ImmunoTargets and Therapy · doi:10.2147/itt.s240891 · Cited by 127
Th17 cells and inflammation in neurological disorders: Possible mechanisms of action
Shi, Y., Wei, B., Li, L., Wang, B., & Sun, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.932152 · Cited by 108
Metadata
- Authors
- Alvarez-Mon, M. A., Gómez-Lahoz, A. M., Orozco, A., Lahera, G., Diaz, D., Ortega, M. A., Albillos, A., Quintero, J., Aubá, E., Monserrat, J., & Alvarez-Mon, M.
- Affiliations
- Department of Psychiatry and Medical Psychology, University Clinic of Navarra, Avda. Pío XII, 36, 31008 Pamplona, Spain
- Department of Medicine and Medical Specialities, University of Alcala, 28871 Alcala de Henares, Spain
- Hospital Universitario Príncipe de Asturias (ES)
- Universidad de Alcalá (ES)
- Universidad Complutense de Madrid (ES)
- Clinica Universidad de Navarra (ES)
- Venue
- Journal of Personalized Medicine
- Publisher
- MDPI AG
- Published
- 2021-03-19
- Volume
- 11
- Issue
- 3
- Pages
- 220
- ISSN
- 2075-4426 (ISSN-L)
- PMC
- PMC8003656
- OpenAlex
- W3136411448
- Cited by
- 57
- References
- 44
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 7 · 2023: 12 · 2022: 12 · 2021: 14
- FWCI
- 3.74
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Personalized Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- e_Buah (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Instituto de Salud Carlos III (PI18/01726))
- Comunidad de Madrid (B2017/BMD-3804)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- major depressive disorder, CD4+ T cells, Th17 cells, IL-17, TNF-α, interferon-gamma, Th1/Th2 balance, central memory T cells, effector memory T cells, naive T cells, effector T cells, CD28, cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.